These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1900910)

  • 21. Antiplatelet therapy in the prevention of stroke.
    Easton JD
    Drugs; 1991; 42 Suppl 5():39-50. PubMed ID: 1726215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
    Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
    BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomised trial of prophylactic daily aspirin in British male doctors.
    Peto R; Gray R; Collins R; Wheatley K; Hennekens C; Jamrozik K; Warlow C; Hafner B; Thompson E; Norton S
    Br Med J (Clin Res Ed); 1988 Jan; 296(6618):313-6. PubMed ID: 3125882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention.
    Mehta SR; Yusuf S
    J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):79S-88S. PubMed ID: 12644345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspirin as an antithrombotic drug: from the aggregometer to clinical trials.
    de Gaetano G
    Verh K Acad Geneeskd Belg; 1990; 52(6):459-71; discussion 471-3. PubMed ID: 2150736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.
    Aguilar M; Hart R
    Cochrane Database Syst Rev; 2005 Oct; (4):CD001925. PubMed ID: 16235290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients.
    Hankey GJ; Sudlow CL; Dunbabin DW
    Cochrane Database Syst Rev; 2000; (2):CD001246. PubMed ID: 10796426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54).
    Bonaca MP; Goto S; Bhatt DL; Steg PG; Storey RF; Cohen M; Goodrich E; Mauri L; Ophuis TO; Ruda M; Špinar J; Seung KB; Hu D; Dalby AJ; Jensen E; Held P; Morrow DA; Braunwald E; Sabatine MS
    Circulation; 2016 Sep; 134(12):861-71. PubMed ID: 27576775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validity of composite outcomes in meta-analyses of stroke prevention trials: the case of aspirin.
    McGrath E; O'Conghaile A; Eikelboom JW; Dinneen SF; Oczkowski C; O'Donnell MJ
    Cerebrovasc Dis; 2011; 32(1):22-7. PubMed ID: 21576939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithrombotic drugs for the secondary prevention of ischemic stroke.
    Nenci GG; Goracci S
    Ann Ital Med Int; 2000; 15(4):282-90. PubMed ID: 11202630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events.
    Bowry AD; Brookhart MA; Choudhry NK
    Am J Cardiol; 2008 Apr; 101(7):960-6. PubMed ID: 18359315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monotherapy with a P2Y
    Chiarito M; Sanz-Sánchez J; Cannata F; Cao D; Sturla M; Panico C; Godino C; Regazzoli D; Reimers B; De Caterina R; Condorelli G; Ferrante G; Stefanini GG
    Lancet; 2020 May; 395(10235):1487-1495. PubMed ID: 32386592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease.
    Robless P; Mikhailidis DP; Stansby G
    Br J Surg; 2001 Jun; 88(6):787-800. PubMed ID: 11412247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of antiplatelet therapy in preventing thrombotic events in generalized vascular disease.
    Montalescot G
    Clin Cardiol; 2000 Nov; 23 Suppl 6(Suppl 6):VI-18-22. PubMed ID: 11129682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease.
    Aronow WS
    Drugs Aging; 1999 Aug; 15(2):91-101. PubMed ID: 10495069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triflusal for preventing serious vascular events in people at high risk.
    Costa J; Ferro JM; Matias-Guiu J; Alvarez-Sabin J; Torres F
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004296. PubMed ID: 16034926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiplatelet therapy for acute ischaemic stroke.
    Sandercock PA; Counsell C; Gubitz GJ; Tseng MC
    Cochrane Database Syst Rev; 2008 Jul; (3):CD000029. PubMed ID: 18646056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of cardiovascular disease: risks and benefits of aspirin.
    Buring JE; Hennekens CH
    J Gen Intern Med; 1990; 5(5 Suppl):S54-7. PubMed ID: 2231066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials.
    Berger JS; Krantz MJ; Kittelson JM; Hiatt WR
    JAMA; 2009 May; 301(18):1909-19. PubMed ID: 19436018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiplatelet therapy for acute ischaemic stroke.
    Gubitz G; Sandercock P; Counsell C
    Cochrane Database Syst Rev; 2000; (2):CD000029. PubMed ID: 10796284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.